Brad Hively, Director at Oncology Institute, Inc. (TOI), sold 3,952,274 shares at $2.87 ($11.3M) on 2025-06-03, disclosed to the SEC on 2025-06-05.
Open-market sale of $11.3M TOI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.87 | 108,532 | $311K | 2.7% |
| 2 | $2.87 | 108,532 | $311K | 2.7% |
| 3 | $2.87 | 1,867,605 | $5.4M | 47.3% |
| 4 | $2.87 | 1,867,605 | $5.4M | 47.3% |
| Total | $2.87 avg | 3,952,274 | $11.3M | 100% |
| Filing → |
| TOI | SELL | 2025-08-21 | $164K | — | Filing → |
| TOI | BUY | 2025-04-28 | $47K | — | Filing → |
| TOI | BUY | 2025-03-28 | $9K | — | Filing → |